79559-08-3 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 2-(3,5-dimethyl-1H-pyrazol-1-yl)acetate is used as a reactant in the preparation of 3-oxo-1,2-diazetidinium tosylate, which is an important intermediate in the synthesis of pharmaceutical compounds. This intermediate can be further utilized in the development of drugs with potential therapeutic applications.
Used in Chemical Synthesis:
In the field of chemical synthesis, methyl 2-(3,5-dimethyl-1H-pyrazol-1-yl)acetate serves as a versatile building block for the creation of various organic molecules. Its reactivity and functional groups make it suitable for use in a wide range of reactions, including condensation, substitution, and rearrangement processes.
Used in Research and Development:
Methyl 2-(3,5-dimethyl-1H-pyrazol-1-yl)acetate is also used in research and development settings to explore its chemical properties and potential applications. Scientists and researchers may use methyl 2-(3,5-dimethyl-1H-pyrazol-1-yl)acetate to investigate new reaction pathways, develop novel synthetic methods, or study its interactions with other molecules in various chemical systems.
Check Digit Verification of cas no
The CAS Registry Mumber 79559-08-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,5,5 and 9 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 79559-08:
(7*7)+(6*9)+(5*5)+(4*5)+(3*9)+(2*0)+(1*8)=183
183 % 10 = 3
So 79559-08-3 is a valid CAS Registry Number.
79559-08-3Relevant academic research and scientific papers
CHEMICAL SUBSTANCES WHICH INHIBIT THE ENZYMATIC ACTIVITY OF HUMAN KALLIKREIN-RELATED PEPTIDASE 6 (KLK6)
-
Paragraph 0361; 0362, (2018/04/19)
The invention relates to compounds which are suitable for the treatment of a disease associated with kallikrein-like peptidase 6 overexpression and to pharmaceutical compositions containing such compounds. The invention further relates to a kit of parts comprising such compounds or pharmaceutical compositions.
Asymmetric borane reduction of ketones catalyzed by N-hydroxyalkyl-l-menthopyrazoles
Kashima,Tsukamoto,Higashide,Nakazono
, p. 983 - 990 (2007/10/03)
The equimolar mixture of N-(hydroxyalkyl)pyrazoles and borane formed boric ester complex, in which the remaining borane was stabilized by the adjacent nitrogen of thr pyrazole ring. The borane complex derived from the chiral pyrazoles such as 3-phenyl-l-menthopyrazole reduced p-methylacetophenone (21) enantioselectively. When (2'S)-2-(2'-phenyl-2'-hydroxyethyl)-3-phenyl-l-menthopyrazole ((2'S)-10b) was used, 21 was reduced into (S)-p-methylphenyl-1-ethanol (22) in moderate chemical and optical yields. Due to the inconvenience of the preparation and the lower optical yield, the use of N-(α-hydroxyalkyl)pyrazoles was unpromising for the enantioselective reduction of ketones by borane.
